March 3 (Reuters) - Adverum Biotechnologies Inc ADVM.O:
ADVERUM BIOTECHNOLOGIES INITIATES ARTEMIS PHASE 3 STUDY EVALUATING IXO-VEC FOR WET AMD
Source text: ID:nGNX835Yyx
Further company coverage: ADVM.O
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.